Posts Tagged ‘Genetic Testing’
Genetic Testing Challenges in Oncology: Confusion Over Colon Cancer Syndromes Leads to Wrong Testing
Precision Oncology News and My Gene Counsel have partnered to produce the “Genetic Testing Challenges in Oncology” series to highlight real-world issues that genetics experts and medical professionals are encountering as genetic tests are increasingly used in cancer care. Experts submit anonymized case reports to My Gene Counsel, and based on the details in these reports,…
Read MoreDespite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing
Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for their inherited risks for cancers.
Read MoreEllen Matloff’s Forbes Article: A Genetic Counselor’s Take On Why America Should Not Collect DNA From Migrants
Last week, three House Democrats called on the Department of Homeland Security (DHS) to stop collecting DNA from migrants in government custody. Democratic Reps. Rashida Tlaib (MI), Veronica Escobar (TX), and Congressional Hispanic Caucus Chairman Joaquin Castro (TX) called the collection of DNA samples a “serious human rights issue” in their letter to DHS Secretary Chad Wolf.
Read MoreGenetic Testing Challenges in Oncology: Patient Told Genetic Test Was Negative Turns out to Be MAP Carrier
Precision Oncology News and My Gene Counsel have partnered to produce the “Genetic Testing Challenges in Oncology” series to highlight real-world issues that genetics experts and medical professionals are encountering as genetic tests are increasingly used in cancer care. Experts submit anonymized case reports to My Gene Counsel, and based on the details in these reports,…
Read MoreWith More Than a Million Records, ClinVar Value Grows as Variant Classification Resource
Since its launch in 2013, ClinVar has not only amassed a wealth of genetic variant information, but the lab and clinical genetics communities in the U.S. are readily referencing it when they have questions about the clinical significance of variants.
Read MorePersonalized Medicine in 2019: Options Increasing But Are They Reaching Patients?
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether they are likely to respond to therapy.
Read More